Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,096.82
-0.1118-0.01%
Number of Gainers:505
Number of Losers:488
Number of Flat:28
PE:- -
High:2,100.64
Open:2,096.97
Low:2,093.04
Close:2,096.93
Volume:5.03B
Turnover:643.03B
Market Cap:97.53T
Float Cap:91.30T

Loading ...

Sealsq Attends IQT Quantum+AI Conference as Titanium Sponsor, CEO Set to Deliver Keynote

Reuters
·
Oct 08

Is Ping An Healthcare and Technology (SEHK:1833) A Bargain As Valuation Signals Diverge?

Simply Wall St.
·
Oct 08

ECGI Holdings Extinguishes $2.56 Million Convertible Obligation

Reuters
·
Oct 08

Firefly Unit SciTec Expands US Air Force CBC2 Contract by $1.5 Million to Add Counter-UAS Data Feeds

Reuters
·
Oct 08

Retrieve Medical Strikes National Distribution Deal for Retrieve Passport with US Financial Services Platform

Reuters
·
Oct 08

Callan JMB Signs Initial Truking Equipment Order, Plans $500,000 Down Payment

Reuters
·
Oct 08

JP3E Holdings Issues Common Stock Warrants with $19.21 Million Aggregate Exercise Value

Reuters
·
Oct 08

Newegg Adds Google UCP Checkout for In-Conversation Purchases in Gemini, Search AI Mode

Reuters
·
Oct 08

Arqit Expects Fy2026 Revenue of $975,000-$1,000,000

Reuters
·
Oct 08

DFDS Wins Spanish, Moroccan Antitrust Clearance for Algeciras-Tangier Med Acquisition

Reuters
·
Oct 08

Draganfly CEO Cameron Chell Joins Raymond James Aerospace, Defense Conference Panel

Reuters
·
Oct 08

ZenaTech Unit ZenaDrone Begins Building Mobile Operations Trailer for Multi-Drone Farm Jobs

Reuters
·
Oct 08

Crispr Therapeutics to Present Phase 1b Ctx310 Data in Severe Hypertriglyceridemia at AHA 2026

Reuters
·
Oct 08

US Stock Index Futures Edge Lower as Chip Stocks Underperform

Deep News
·
Oct 08

AI Chip Production Outpaces Data Center Capacity as Power Shortages Threaten Semiconductor Shipment Forecasts

Deep News
·
Oct 08

Eminence Grey and Lumen Partner to Deliver Sovereign AI Infrastructure Across the U.S.

THOMSON REUTERS
·
Oct 08

Vir Biotechnology Announces Psma-Targeted Pro-Xten® Dual-Masked T-Cell Engager Vir-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer

THOMSON REUTERS
·
Oct 08

Vir Biotechnology - Phase 3 Trials for Vir-5500 Anticipated to Begin in 2027

THOMSON REUTERS
·
Oct 08

SEALSQ and WISeSat.Space to Showcase Root-to-Qubit-to-Space Stack at IQT Quantum+Ai Event in New York

GlobeNewswire
·
Oct 08

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2026

GlobeNewswire
·
Oct 08